Celestica (CLS) Earnings Analysis
Celestica (CLS) next reports earnings on 2026-07-27, consensus EPS 2.29 USD. Last quarter (2026-04-27) it beat with EPS 2.16 USD vs 2.08 USD est (+3.8%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 40.23.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLS next report earnings?
| Next earnings date | 2026-07-27 |
|---|---|
| Consensus EPS estimate | 2.29 USD |
| Revenue estimate | 4.30B |
CLS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 2.16 USD | 2.08 USD | +3.8% | Beat |
| 2026-01-28 | 1.89 USD | 1.74 USD | +8.6% | Beat |
| 2025-10-27 | 1.58 USD | 1.47 USD | +7.5% | Beat |
| 2025-07-28 | 1.39 USD | 1.24 USD | +12.1% | Beat |
| 2025-01-29 | 1.11 USD | 1.04 USD | +6.7% | Beat |
| 2024-10-23 | 1.04 USD | 0.94 USD | +10.6% | Beat |
| 2024-07-24 | 0.91 USD | 0.81 USD | +12.3% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
CLS valuation and analyst view
| Trailing P/E | 40.23 |
|---|---|
| Trailing EPS | 8.353 USD |
| Price / book | 18.82 |
| Dividend yield | 0.00% |
| Market cap | 38.93B |
| Analyst consensus | Buy (17 buy / 10 hold / 0 sell) |
| Avg price target | 459 USD |
Related research pages
Frequently asked questions
When is Celestica (CLS)'s next earnings date?
Celestica is next scheduled to report on 2026-07-27, with a consensus EPS estimate of 2.29 USD and revenue estimate of 4.30B.
Did CLS beat earnings last quarter?
In its 2026-04-27 report, CLS posted EPS of 2.16 USD versus a 2.08 USD estimate — a beat of 3.8%.
What is CLS's earnings track record?
Over the last 7 reported quarters with consensus data, CLS beat estimates 7 times (100%).
What is CLS's current P/E ratio and EPS?
CLS trades at a trailing P/E of 40.23 on trailing EPS of 8.352854308093995 USD.
What do analysts rate CLS?
Analyst consensus is "Buy" across 27 ratings (0 strong buy, 17 buy, 10 hold, 0 sell, 0 strong sell). Average 12-month price target: 459 USD.